在患有帕金森病的患者中使用抗重力跑步机"Alter-G"来增强步行训练
Desireè Latella1, Antonino Lombardo Facciale1, Mirjam Bonanno1
1I.R.C.C.S. Centro Neurolesi Bonino Pulejo, Messina, Italy.
PloS one
|February 25, 2026
概括
体重支持的跑步机训练改善了帕金森病 (PD) 患者的步行速度,步伐长度,平衡和姿势稳定性. 这种新的方法还减少了对跌倒的恐惧,提高了生活质量,提供了一个有希望的康复策略.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 运动障碍 运动障碍
背景情况:
- 走路结 (FoG) 是帕金森病 (PD) 的常见和致残症状,严重影响患者的行动能力和独立性.
- 现有的PD治疗方法,包括药物和神经调节,往往不能完全缓解症状,这凸显了对替代治疗方法的需求.
研究的目的:
- 研究以体重为支的跑步机训练的有效性,利用差异化的空气压力来改善PD患者的步态和运动能力.
主要方法:
- 一项随机对照试验,涉及40名PD患者,分别分配到接受正气压跑步机训练的实验组 (EG) 或接受常规物理治疗的对照组 (CG).
- 两组人都接受了四个月的每周两次培训,在基线和干预后进行评估.
- 主要结局包括步行速度,步长,平衡和姿势稳定;次要结局包括生活质量,跌倒恐惧和焦虑程度.
主要成果:
- 与对照组相比,实验组在步行速度,步骤长度,平衡和姿势稳定方面表现出了统计学上显著的改善 (p < 0.01).
- 实验组的患者还报告说,对跌倒的恐惧有显著的减少,生活质量得分有所改善 (p < 0.01).
结论:
- 带有差异气压的体重支持跑步机训练显示出作为一种有效的补充疗法,有潜力改善PD患者的步态,平衡和整体生活质量.
- 这些初步发现表明,这种创新的康复策略需要在更大规模的临床试验中进行进一步的研究,以确认其对PD患者的益处.
更多相关视频
06:00A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
1.3K
07:21Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
Published on: June 16, 2023
1.6K
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
